It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative, fatal and currently incurable disease. People with ALS need support from informal caregivers due to the motor and cognitive decline caused by the disease. This study aims to identify caregivers whose quality of life (QoL) may be impacted as a result of caring for a person with ALS. In this study, we worked towards the identification of the predictors of a caregiver’s QoL in addition to the development of a model for clinical use to alert clinicians when a caregiver is at risk of experiencing low QoL. The data were collected through the Irish ALS Registry and via interviews on several topics with 90 patient and caregiver pairs at three time-points. The McGill QoL questionnaire was used to assess caregiver QoL—the MQoL Single Item Score measures the overall QoL and was selected as the outcome of interest in this work. The caregiver’s existential QoL and burden, as well as the patient’s depression and employment before the onset of symptoms were the features that had the highest impact in predicting caregiver quality of life. A small subset of features that could be easy to collect was used to develop a second model to use it in a clinical setting. The most predictive features for that model were the weekly caregiving duties, age and health of the caregiver, as well as the patient’s physical functioning and age of onset.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University College Dublin, School of Computer Science, Dublin 4, Ireland (GRID:grid.7886.1) (ISNI:0000 0001 0768 2743); Royal College of Surgeons in Ireland, FutureNeuro, SFI Research Centre for Chronic and Rare Neurological Diseases, Dublin 2, Ireland (GRID:grid.4912.e) (ISNI:0000 0004 0488 7120)
2 Trinity College Dublin, Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Dublin 2, Ireland (GRID:grid.8217.c) (ISNI:0000 0004 1936 9705)
3 Royal College of Surgeons in Ireland, FutureNeuro, SFI Research Centre for Chronic and Rare Neurological Diseases, Dublin 2, Ireland (GRID:grid.4912.e) (ISNI:0000 0004 0488 7120); Trinity College Dublin, Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Dublin 2, Ireland (GRID:grid.8217.c) (ISNI:0000 0004 1936 9705); Beaumont Hospital, Department of Neurology, Dublin 9, Ireland (GRID:grid.414315.6) (ISNI:0000 0004 0617 6058)